Abstract
The erythromycins are broadly reviewed from a clinical viewpoint. The antimicrobial spectrum, clinical indications, pharmacokinetics and toxicity are dealt with. The usefulness of erythromycin for respiratory tract infections is stressed. New evidence to support bactericidal activity of this antibiotic is noted. There seems little reason to use the potentially hepatotoxic estolate form of erythromycin. The safety of the other forms of this antibiotic available in this country is emphasized.
摘要
相似文献
1
Another look at erythromycin.
S Afr Med J. 1978 Apr 8;53(14):527-30.
2
A new look at erythromycin.红霉素新视角。
Postgrad Med J. 1977 Apr;53(618):195-200. doi: 10.1136/pgmj.53.618.195.
3
Drug therapy reviews: antimicrobial spectrum, pharmacology and therapeutic use of erythromycin and its derivatives.
Am J Hosp Pharm. 1979 Sep;36(9):1185-9.
4
Erythromycin--three decades later.红霉素——三十年之后。
S Afr Med J. 1983 Aug 6;64(6):197-201.
5
Treatment of acute bacterial infections of the upper respiratory tract.
Curr Med Res Opin. 1977;4(8):544-54. doi: 10.1185/03007997709115269.
6
[Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
Pathol Biol (Paris). 1988 May;36(5):544-7.
7
The erythromycins.
Ear Nose Throat J. 1981 May;60(5):222-3.
8
Antibiotic resistance: relationship to persistence of group A streptococci in the upper respiratory tract.
Pediatrics. 1996 Jun;97(6 Pt 2):971-5.
9
Selection of an oral erythromycin product.口服红霉素产品的选择。
Am J Hosp Pharm. 1980 Sep;37(9):1199-205.
10
Intravenous erythromycin in acute chest infections in critically ill patients.
Anaesth Intensive Care. 1979 May;7(2):143-7. doi: 10.1177/0310057X7900700205.
Zotero 插件